Skip to content Back to top
 

FOI 2025/1207

Reference FOI 2025/1207
Description Inquiry on Myocardial Perfusion Imaging Procedures and Regadenoson Usage
Date Requested 25/04/2025
Date Replied 01/05/2025
Category Strategic Clinical Networks (SCN)

I attempted to gather data on the number of Myocardial Perfusion Imaging (MPI) procedures & Regadenoson usage in the UK but found limited information from the sources.

So, I would like to inquire about the following:

  1. The number of myocardial perfusion imaging (MPI) procedures performed over the last 5 years, categorized by technique (e.g., SPECT, PET, CMR, etc.).
  2. The percentage of these procedures that utilized pharmacological stress agents along with preferred agent by technique if available.
  3. The total usage of Regadenoson injection (number of vials) by technique over the past 5 years.

Scope of my request: As a pharmaceutical company, we are currently conducting a comprehensive portfolio evaluation to identify new opportunities for product development and introduction into the UK market. We have identified the diagnostic sector, particularly the cardiac imaging segment, as a promising area due to the increasing prevalence of cardiovascular disease within the population. To better understand the market potential and make informed decisions, we require additional data and insights

NHS Greater Manchester (NHS GM) does not hold the information requested. Therefore, it will be necessary for you to direct your request to the NHS health care provider organisations for the information you seek. To assist you please find below links to the trust websites and information about how to make a Freedom of Information request.

 

Return to FOI Requests

Launch Recite Me assistive technology